Teoh JY - Search Results

1

M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.

Zhong C, Long Z, Yang T, Wang S, Zhong W, Hu F, Teoh JY, Lu J, Mao X. Zhong C, et al. Among authors: teoh jy. Int J Biol Sci. 2023 Mar 5;19(5):1543-1563. doi: 10.7150/ijbs.77133. eCollection 2023. Int J Biol Sci. 2023. PMID: 37056926 Free PMC article.

2

The Emerging Clinical Role of Spermine in Prostate Cancer.

Peng Q, Wong CY, Cheuk IW, Teoh JY, Chiu PK, Ng CF. Peng Q, et al. Among authors: teoh jy. Int J Mol Sci. 2021 Apr 22;22(9):4382. doi: 10.3390/ijms22094382. Int J Mol Sci. 2021. PMID: 33922247 Free PMC article. Review.

3

GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.

Peng Q, Xie T, Wang Y, Ho VW, Teoh JY, Chiu PK, Ng CF. Peng Q, et al. Among authors: teoh jy. Int J Mol Sci. 2023 Dec 29;25(1):489. doi: 10.3390/ijms25010489. Int J Mol Sci. 2023. PMID: 38203661 Free PMC article.

4

Chemohormonal therapy for metastatic hormone-sensitive prostate cancer: An Asian perspective.

Teoh JY, Ng CF, Poon DM. Teoh JY, et al. Asia Pac J Clin Oncol. 2018 Nov;14 Suppl 5:5-8. doi: 10.1111/ajco.13060. Asia Pac J Clin Oncol. 2018. PMID: 30489034 Review.

5

Implications and effects of COVID-19 on diagnosis and management of prostate cancer.

Chan VW, Asif A, Koe JS, Ng A, Ng CF, Teoh JY. Chan VW, et al. Among authors: teoh jy. Curr Opin Urol. 2022 May 1;32(3):311-317. doi: 10.1097/MOU.0000000000000973. Epub 2022 Feb 9. Curr Opin Urol. 2022. PMID: 35142745 Review.

6

Role of PSA density in diagnosis of prostate cancer in obese men.

Chiu PK, Teoh JY, Chan SY, Chu PS, Man CW, Hou SM, Ng CF. Chiu PK, et al. Among authors: teoh jy. Int Urol Nephrol. 2014 Dec;46(12):2251-4. doi: 10.1007/s11255-014-0826-7. Epub 2014 Sep 9. Int Urol Nephrol. 2014. PMID: 25201460

7

Prognostic significance of time to prostate-specific antigen (PSA) nadir and its relationship to survival beyond time to PSA nadir for prostate cancer patients with bone metastases after primary androgen deprivation therapy.

Teoh JY, Tsu JH, Yuen SK, Chan SY, Chiu PK, Lee WM, Wong KW, Ho KL, Hou SS, Ng CF, Yiu MK. Teoh JY, et al. Ann Surg Oncol. 2015 Apr;22(4):1385-91. doi: 10.1245/s10434-014-4105-8. Epub 2014 Sep 19. Ann Surg Oncol. 2015. PMID: 25234025

8

Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level.

Teoh JY, Tsu JH, Yuen SK, Chan SY, Chiu PK, Wong KW, Ho KL, Hou SS, Ng CF, Yiu MK. Teoh JY, et al. Asia Pac J Clin Oncol. 2017 Apr;13(2):e65-e71. doi: 10.1111/ajco.12313. Epub 2014 Dec 3. Asia Pac J Clin Oncol. 2017. PMID: 25471685

9

Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF. Teoh JY, et al. Jpn J Clin Oncol. 2015 May;45(5):483-7. doi: 10.1093/jjco/hyv025. Epub 2015 Feb 26. Jpn J Clin Oncol. 2015. PMID: 25724216

10

Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer.

Teoh JY, Chiu PK, Chan SY, Poon DM, Cheung HY, Hou SS, Ng CF. Teoh JY, et al. Aging Male. 2015;18(3):180-5. doi: 10.3109/13685538.2015.1046043. Epub 2015 May 25. Aging Male. 2015. PMID: 26004988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

358 results

Search Page